Mission statement · Company scope
“Our mission is to accelerate the discovery, development and global access to targeted radioligand therapies.”
In use2023 – now1 sighting
First seenMar 2023Added
Last seenMar 2023Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Democratization
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Plain
- Length
- 15 words · reading grade 17
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_c66768ba6ef2a91e
- Classification confidence
- 0.67
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2023-03-27 · sec_sentence · 10-K · accession 0001811764-23-000007
View filing ↗0 to compareCompare